an zoomed out icon of an obese female patient discussing with her doctor

Addressing
Obesity
in the Clinic

Treatment Modalities

Lifestyle changes, psychological interventions, pharmacological management, and bariatric surgery are the key treatment modalities for obesity.1-3

Lifestyle Modification2,4

Medical nutrition therapy:

  • Long-term adherence to a healthy eating pattern that is personalized to meet individual values and preferences

Increased exercise:

  • At least 150 minutes of physical activity per week

Pharmacotherapy (approved in India)5-7

NameClassYear approved
OrlistatPancreatic lipase inhibitor1999
Semaglutide (sc)GLP-1 receptor agonist2021
TirzepatideGIP/GLP-1 receptor agonist2024

Bariatric Surgery2 can be considered for people with

  • BMI of ≥40 kg/m2 or
  • BMI of ≥35 kg/m2 with at least 1 adiposity-related disease (level 4, grade D, consensus)
  • Bariatric surgery should be considered in patients with poorly controlled type 2 diabetes and class I obesity (BMI between 30 and 35 kg/m2) despite optimal medical management. (Level 1a, grade A)
  • Bariatric surgery may be considered for weight loss and/or to control adiposity-related diseases in persons with class 1 obesity, in whom optimal medical and behavioral management has been insufficient to produce significant weight loss. (Level 2a, grade B)

Effective partnership is essential for long-term success2

The “5 As” model can help you discuss weight management with your patients8

Find important information on treatment modalities for obesity

  1. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):1-203. doi:10.4158/EP161365.GL

  2. Wharton S, Lau DCW, Vallis M, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020;192(31):E875-E891. doi:10.1503/cmaj.191707

  3. Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond). 2019;19(3):205-212. doi:10.7861/clinmedicine.19-3-205

  4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038

  5. Garvey WT. New horizons. A new paradigm for treating to target with second-generation obesity medications. J Clin Endocrinol Metab. 2022;107(4):e1339-e1347. doi:10.1210/clinem/dgab848

  6. Bersoux S, Byun TH, Chaliki SS, Poole KG. Pharmacotherapy for obesity: what you need to know. Cleve Clin J Med. 2017;84(12):951-958. doi:10.3949/ccjm.84a.16094

  7. Mounjaro (tirzepatide once weekly) India Prescribing Information Sept 2024.

  8. Vallis M, Piccinini-Vallis H, Sharma AM, Freedhoff Y. Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care. Can Fam Physician. 2013;59(1):27-31.